Human Papilloma Virus-Induced Cervical Cancer in Nigeria: Epidemiology, challenges, prevention and future perspective
Journal of Public Health and Diseases · 30.08.2025 · 7 (4) · 91-97
DOI: 10.31248/jphd2025.155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Public Health and Diseases, online erschienen am 30.08.2025. Verfasst von Jephthah Yacham Bagayang und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Cervical cancer is the fourth prevalent cancer among women worldwide, and Human Papillomavirus (HPV) infection is recognised as a major risk factor for its development. Sub-Saharan Africa records the highest rates of cervical cancer globally, emerging as the predominant cause of mortality among women in 21 out of the 48 countries within the region. In Nigeria, the prevalence of HPV-induced cervical cancer is a major public health concern. The review aimed at examining the burden of HPV-induced cervical cancer and exploring potential solutions. An English-language literature search was conducted on PubMed, Scopus, and Embase, as well as existing systematic reviews, speciality journals, and several websites, including Google. Medical Subject Headings (MeSH) terms were used to search for relevant articles before March 2, 2024. Lack of awareness and education about HPV and cervical cancer, limited access to HPV vaccination and screening programs, stigma and sociocultural barriers in seeking early diagnosis and treatment for cervical cancer were identified as challenges in tackling HPV-induced cervical cancer in Nigeria. The major noted key strategies for the prevention and control of HPV induced cervical cancer in Nigeria were: Promoting HPV vaccination programs and awareness campaigns, strengthening screening and early detection initiatives, improving access to quality treatment and care services and enhancing healthcare infrastructure and workforce capacity were considered as the strategies for prevention and control of HPV-induced cervical cancer in Nigeria. Moving forward, collaborative efforts are crucial, necessitating encouraging multi-sectoral collaboration and partnerships, advocating for policy changes and implementation, integrating cervical cancer programs into primary healthcare and monitoring and evaluation of HPV-induced cervical cancer programs.
Zitieren
APA
Bagayang, J. Y., Danbaki, K. E., & Inumanye, O. (2025). Human Papilloma Virus-Induced Cervical Cancer in Nigeria: Epidemiology, challenges, prevention and future perspective. Journal of Public Health and Diseases, 7(4), 91-97. https://doi.org/10.31248/jphd2025.155
Vancouver
Bagayang JY, Danbaki KE, Inumanye O. Human Papilloma Virus-Induced Cervical Cancer in Nigeria: Epidemiology, challenges, prevention and future perspective. Journal of Public Health and Diseases. 2025;7(4):91-97. doi:10.31248/jphd2025.155
BibTeX
@article{Bagayang2025,
author = {Bagayang, Jephthah Yacham and Danbaki, Kimbi Enoch and Inumanye, Ojule},
title = {Human Papilloma Virus-Induced Cervical Cancer in Nigeria: Epidemiology, challenges, prevention and future perspective},
journal = {Journal of Public Health and Diseases},
year = {2025},
volume = {7},
number = {4},
pages = {91--97},
doi = {10.31248/jphd2025.155}
}
EUVIMED